|
|
Volumn 334, Issue 21, 1996, Pages 1396-1397
|
|
β-Adrenergic blockers and survival in heart failure
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUCINDOLOL;
CARVEDILOL;
DIGITALIS GLYCOSIDE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FLOSEQUINAN;
HYDRALAZINE;
MILRINONE;
NITRATE;
BETA ADRENERGIC RECEPTOR BLOCKING;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
EDITORIAL;
HEART FAILURE;
HEART RATE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADRENERGIC BETA-ANTAGONISTS;
CARBAZOLES;
HEART FAILURE, CONGESTIVE;
HUMANS;
PROPANOLAMINES;
|
|
EID: 0029988170
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199605233342109 Document Type: Editorial |
|
Times cited : (100)
|
|
References (0)
|
